Autologous Transplantation May Still Effectively Treat Relapsed Diffuse Large B-Cell Lymphoma in Selected Patients

SIMPLE SUMMARY: Treating relapsed and refractory diffuse large B-cell lymphoma is still challenging for clinicians. CAR-T cell therapy changed the role of autologous stem cell transplantation in r/r DLBCL patients. The aim of our retrospective study was to assess our data to determine achievable res...

Descripción completa

Detalles Bibliográficos
Autores principales: Bicsko, Reka Rahel, Antal, Lili, Magyari, Ferenc, Szász, Róbert, Udvardy, Miklós, Illes, Arpad, Gergely, Lajos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296386/
https://www.ncbi.nlm.nih.gov/pubmed/37370833
http://dx.doi.org/10.3390/cancers15123223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296386/
https://www.ncbi.nlm.nih.gov/pubmed/37370833
http://dx.doi.org/10.3390/cancers15123223

Ejemplares similares